跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
hydralazine + isosorbide dinitrate
首页
药物
hydralazine + isosorbide dinitrate
hydralazine + isosorbide dinitrate
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochrloride
US 2007098796 A1
申请人: REKHI GURVINDER S
优先权: 2005
US
8 件公开
KITS OF HYDRALAZINE COMPOUNDS AND ISOSORBIDE DINITRATE AND/OR ISOSORBIDE MONONITRATE
US 2008226752 A1
申请人: NITROMED INC
优先权: 2000
US
5 件公开
Methods of treating vascular diseases characterized by nitric oxide insufficiency
US 7708989 B2
申请人: NITROMED INC
优先权: 2003
US
4 件公开
US 7235237 B2
申请人: NITROMED INC
优先权: 2003
US
2 件公开
Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
US 7138430 B2
申请人: NITROMED INC
优先权: 2003
US
4 件公开
Methods for reducing hospitalizations related to heart failure
US 2006014829 A1
申请人: NITROMED INC
优先权: 2005
US
4 件公开
Transdermal patch composition for treating vascular diseases characterized by nitric oxide insufficiency
US 7556824 B2
申请人: NITROMED INC
优先权: 2000
US
3 件公开
Composition for treating vascular diseases characterized by nitric oxide insufficiency
US 7537785 B2
申请人: NITROMED INC
优先权: 2003
US
2 件公开
Methods for treating blood disorders with nitric oxide donor compounds
US 2007191377 A1
申请人: NITROMED INC
优先权: 2005
US
Compositions comprising nebivolol
EP 2174658 A1
申请人: MYLAN LAB INC
优先权: 2005
EP
Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride
US 2007098791 A1
申请人: REKHI GURVINDER S
优先权: 2006
US
第 1 / 2 页
上一页
下一页
药物
反馈